Sign In
Buy ILMN
$205.10
+0.0100 (+0.0049%)
At Close: Jul 31, 2026
7 Beaten-Down Stocks to Buy Right Now for a June Rebound
12:25pm, Monday, 07'th Jun 2021
Are you looking for stocks that have been beaten up in recent weeks? Here are seven stocks to buy right now at the start of the summer.
This Biotech Just Made History. Will Its Stock Follow?
12:55pm, Friday, 04'th Jun 2021
Twenty years after the human genome was sequenced, a new wave of discovery has begun.
Illumina (ILMN) Expands NIPT Offering With New Collaboration
08:16am, Tuesday, 01'st Jun 2021
Illumina's (ILMN) VeriSeq NIPT Solution v2 provides accurate, consistent and scalable end-to-end genome-wide noninvasive prenatal testing.
Illumina Supports Nationwide Program across Belgium to Assess Whole Genome Sequencing for Developmental Disorders Diagnosis
03:05am, Tuesday, 01'st Jun 2021
SAN DIEGO--(BUSINESS WIRE)--Illumina and BeSolveRD will study the clinical utility and health economic impact of WGS of patients with intellectual disabilities.
Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in Thailand
04:00pm, Monday, 31'st May 2021
MELBOURNE, Australia--(BUSINESS WIRE)--Illumina and Next Generation Genomic Co. announced launch of VeriSeq™ NIPT Solution v2 in Thailand, a CE-IVD, NGS-based approach to NIPT.
Illumina To Webcast Upcoming Investor Conference
05:00pm, Thursday, 27'th May 2021
SAN DIEGO--(BUSINESS WIRE)---- $ILMN #ILMN--Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference: Goldman Sachs 42nd Annual Global He
Is Illumina (ILMN) Outperforming Other Medical Stocks This Year?
12:02pm, Tuesday, 25'th May 2021
Is (ILMN) Outperforming Other Medical Stocks This Year?
With Expenses Growing Faster Than Revenue, Is This Cathie Wood Stock in Trouble?
06:11am, Saturday, 22'nd May 2021
Guardant Health released earnings earlier this month, disappointing investors with its sluggish revenue growth and increasing expenses.
Down More Than 20%, Is This Cathie Wood Biotech A Buy?
06:50am, Thursday, 20'th May 2021
10x Genomics stock has fallen, despite announcing strong first-quarter numbers.
Top 5 S&P 500 Stocks at Lucrative Valuation Amid May Turmoil
09:01am, Wednesday, 19'th May 2021
We have narrowed down our search to five S&P 500 stocks that have attained a 52-week high this year but are currently trading at a deep discount. These are: MAR, PHM, WY, GM and ILMN.
Gene-Sequencing Company With Several Illumina Execs at Top Going Public
06:00pm, Tuesday, 18'th May 2021
Several executives who earned their spurs at dominant genetics sequencing company Illumina Inc. ( ILMN , Financial) hold key management positions at a firm that is planning a $100 million initial publ
SAN DIEGO--(BUSINESS WIRE)--Illumina appoints Susan Tousi as Chief Commercial Officer and Dr. Alex Aravanis as Chief Technology Officer, Head of Research and Product Development
Here's Why You Should Hold on to Illumina (ILMN) Stock for Now
10:31am, Tuesday, 11'th May 2021
Investors continue to be optimistic about Illumina (ILMN), backed by its focus on partnerships and robust adoption of its products.
Why Does Cathie Wood Like This Healthcare Stock So Much?
06:14am, Thursday, 06'th May 2021
Twist Bioscience brings to mind another genomic revolution pioneer.
Illumina: A Highly Valued Play In Genetic Sequencing
01:14pm, Monday, 03'rd May 2021
Illumina's recently released Q1 FY 2021 earnings has seemingly put to rest the fears of slowing growth in the core business. The acquisition of GRAIL has been challenged by US and EU regulators and th
